Skip to main content

Dose-response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial.

Citation
Brown, J. C., et al. “Dose-Response Effects Of Aerobic Exercise On Body Composition Among Colon Cancer Survivors: A Randomised Controlled Trial.”. British Journal Of Cancer, pp. 1614-1620.
Center University of Pennsylvania
Author Justin C Brown, Babette S Zemel, Andrea B Troxel, Michael R Rickels, Nevena Damjanov, Bonnie Ky, Andrew D Rhim, Anil K Rustgi, Kerry S Courneya, Kathryn H Schmitz
Abstract

BACKGROUND: Physical activity is associated with a lower risk of disease recurrence among colon cancer survivors. Excess visceral adipose tissue is associated with a higher risk of disease recurrence among colon cancer survivors. The pathways through which physical activity may alter disease outcomes are unknown, but may be mediated by changes in visceral adipose tissue.

METHODS: Thirty-nine stage I-III colon cancer survivors were randomised to one of three groups: usual-care control, 150 min wk of aerobic exercise (low dose) and 300 min wk of aerobic exercise (high dose) for 6 months. The prespecified key body composition outcome was visceral adipose tissue quantified using dual energy X-ray absorptiometry.

RESULTS: Exercise reduced visceral adipose tissue in dose-response fashion (P=0.008). Compared with the control group, the low- and high-dose exercise groups lost 9.5 cm (95% CI: -22.4, 3.5) and 13.6 cm (95% CI: -27.0, -0.1) in visceral adipose tissue, respectively. Each 60 min wk increase in exercise predicted a 2.7 cm (95% CI: -5.4, -0.1) reduction in visceral adipose tissue.

CONCLUSIONS: Aerobic exercise reduces visceral adipose tissue in dose-response fashion among patients with stage I-III colon cancer. Visceral adipose tissue may be a mechanism through which exercise reduces the risk of disease recurrence among colon cancer survivors.

Year of Publication
2017
Journal
British journal of cancer
Volume
117
Issue
11
Number of Pages
1614-1620
Date Published
11/2017
ISSN Number
1532-1827
DOI
10.1038/bjc.2017.339
Alternate Journal
Br. J. Cancer
PMID
28934762
PMCID
PMC5729439
Download citation